Breaking News Instant updates and real-time market news.

T

AT&T

$34.47

-0.1742 (-0.50%)

, TWX

Time Warner

$88.72

1.01 (1.15%)

10:53
11/21/17
11/21
10:53
11/21/17
10:53

Analysts cut Time Warner, AT&T targets following DOJ lawsuit

Following the news that the U.S. Department of Justice is suing to block AT&T (T) and Time Warner's (TWX) merger deal, several Wall Street analysts lowered their price targets for both names. Nonetheless, Baird analyst William Power argued that he sees the merits of the antitrust case favoring AT&T. DOJ LAWSUIT: Yesterday, the U.S. Department of Justice announced that it is suing to block the deal agreed to between AT&T and Time Warner. Commenting on the news, AT&T's Senior Executive VP and General Counsel David McAtee II said the DOJ lawsuit is "a radical and inexplicable departure from decades of antitrust precedent." He added: "Vertical mergers like this one are routinely approved because they benefit consumers without removing any competitor from the market. We see no legitimate reason for our merger to be treated differently. [...] Fortunately, the Department of Justice doesn't have the final say in this matter. Rather, it bears the burden of proving to the U.S. District Court that the transaction violates the law. We are confident that the Court will reject the Government's claims and permit this merger under longstanding legal precedent." PRICE CUTS: In light of the news that the DOJ will be suing to block the merger, Wells Fargo analyst Marci Ryvicker lowered her price target for Time Warner to $84 from $100 to reflect its standalone value. Looking at Time Warner purely on fundamentals, the analyst told investors that she is not totally sure 2018 estimates are accurate given that the company has given no sense of trends for next year. While Ryvicker acknowledged that many investors have asked what Time Warner is worth, she does not think anyone steps in for it. The analyst reiterated a Market Perform rating on Time Warner's shares. Her peer at Barclays also cut his price target for Time Warner to $92 from $107. Analyst Kannan Venkateshwar argued that the DOJ move "in effect goes against almost 40 years of judicial commentary and action and, therefore, is quite unprecedented." Based on past DOJ frameworks, the analyst believes it may be tough for it to establish competitive harm, but the companies are likely in a 4-6 month period of litigation that should delay not only the closing of the deal but may also "chill other M&A activity across the space." Absent a deal, Venkateshwar estimates Time Warner could trade at $77 per share. Meanwhile, Nomura Instinet analyst Jeffrey Kvaal lowered his price target for AT&T shares to $42 from $45 as he considers shares on fundamentals, while noting that he did not cut his target post the third quarter video miss given the pending deal. Nonetheless, Kvaal told investors he believes the shares have "room to run" with or without Time Warner. CASE MERITS FAVOR AT&T: Commenting on the lawsuit, Baird analyst William Power argued that the merger deal may be delayed, but is not dead. The analyst argued that with Facebook (FB), Google (GOOG; GOOGL), Amazon (AMZN) and Netflix (NFLX) now media forces, including in original content, he finds it difficult to believe that AT&T will be able to significantly raise pricing for the Turner properties or HBO and risk driving away current partners. Ultimately, Power believes the merits of the case favor AT&T. The analyst reiterated an Outperform rating and $42 price target on AT&T shares. PRICE ACTION: In morning trading, shares of Time Warner have gained over 1% to $88.79 while AT&T is fractionally down to $34.42 per share.

T

AT&T

$34.47

-0.1742 (-0.50%)

TWX

Time Warner

$88.72

1.01 (1.15%)

FB

Facebook

$178.74

-0.26 (-0.15%)

GOOG

Alphabet

$1,018.38

-0.71 (-0.07%)

GOOGL

Alphabet Class A

$1,034.66

-1.23 (-0.12%)

AMZN

Amazon.com

$1,126.31

-3.57 (-0.32%)

NFLX

Netflix

$194.10

0.9 (0.47%)

  • 27

    Nov

  • 29

    Nov

  • 29

    Nov

  • 18

    Mar

T AT&T
$34.47

-0.1742 (-0.50%)

11/21/17
CHLM
11/21/17
NO CHANGE
Target $114
CHLM
Buy
Dycom price target raised to $114 from $90 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for Dycom (DY) to $114 from $90 following quarterly results and as the worst of AT&T's (T) spending moderation seems behind it. The analyst reiterates a Buy rating on Dycom's shares.
11/21/17
NOMU
11/21/17
NO CHANGE
Target $42
NOMU
Buy
AT&T price target lowered to $42 from $45 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal lowered his price for AT&T (T) shares target to $42 after the Justice Department filed a lawsuit to block the company's acquisition of Time Warner (TWX). The analyst notes he didn't lowered his target post the Q3 video miss given the pending deal. He believes the shares have "room to run" with or without Time Warner and keeps a Buy rating on AT&T.
11/21/17
BARD
11/21/17
NO CHANGE
Target $42
BARD
Outperform
Merits of antitrust case favor AT&T, says Baird
Baird analyst William Power noted the DOJ sued to block the AT&T (T) and Time Warner (TWX) deal largely on the grounds that the merger would harm consumers due to higher content prices. The analyst finds it difficult to believe that, given other competition, the company would be able to significantly raise pricing for Turner properties or HBO and risk driving away current partners. He said although his thesis is at risk from the suit, he ultimately believes the merits of the case favor AT&T. Power reiterated his Outperform rating and $42 price target on AT&T shares.
11/21/17
DBAB
11/21/17
NO CHANGE
Target $37
DBAB
Hold
AT&T shares likely to remain range-bound, says Deutsche Bank
Deutsche Bank analyst Matthew Niknam expects shares of AT&T (T) to remain relatively range-bound in the near-term due to heightened regulatory risks around the company's proposed merger with Time Warner (TWX). The analyst notes that his standalone AT&T estimates continue to imply flattish earnings growth for Q4 and in upcoming years. He sees the Justice Department suit capping any near-term upside and trimmed his price target for Hold-rated AT&T to $37 from $38.
TWX Time Warner
$88.72

1.01 (1.15%)

11/21/17
WELS
11/21/17
NO CHANGE
Target $84
WELS
Market Perform
Time Warner price target lowered to $84 from $100 at Wells Fargo
Wells Fargo analyst Marci Ryvicker lowered her price target for Time Warner (TWX) to $84 from $100 to reflect standalone value, in light of the recent news that the DOJ will be suing to block the merger with AT&T (T). The analyst reiterates a Market Perform rating on Time Warner's shares.
FB Facebook
$178.74

-0.26 (-0.15%)

11/02/17
COWN
11/02/17
NO CHANGE
COWN
Cowen says Facebook capex step-up positive for Applied Optoelectronics, Arista
Cowen analyst Paul Silverstein said Facebook's (FB) plans to "double" its capital expenditures to $14B from $7B in 2018 represents a significant incremental revenue growth opportunity for optical component and system suppliers, particularly Applied Optoelectronics (AAOI) and Arista Networks (ANET). He thinks Applied is maintaining a strong position at Facebook and would take advantage of weakness in the shares.
11/08/17
UBSW
11/08/17
DOWNGRADE
Target $7
UBSW
Sell
Snap downgraded to Sell from Neutral at UBS
UBS analyst Eric Sheridan downgraded Snap (SNAP) to Sell and cut his price target for the shares to $7 from $12 following last night's Q3 results. The camera company is down 19%, or $2.88, to $12.24 in premarket trading. In a post-earnings research note titled "SNAP Crackle Flop," Sheridan says he finds it very likely that Snap will continue to struggle on "multiple fronts" in the coming 12 months. A redesigned app could bring opportunity but also platform disruption, Sheridan writes. He believes trying to scale its ad business amid "tepid" user growth while competing against Alphabet (GOOG), Facebook (FB) and Amazon.com (AMZN) is likely going to prove difficult for Snap.
11/16/17
KEYB
11/16/17
NO CHANGE
Target $90
KEYB
Overweight
Cavium price target raised to $90 from $80 at KeyBanc
KeyBanc analyst John Vinh raised his price target for Cavium (CAVM) to $90 from $80 as he left SC17 most positive on it as he learned the company is shipping into Facebook (FB) for a late-stage evaluation server cluster and heard positive customer feedback regarding ThunderX2. The analyst reiterates an Overweight rating on Cavium's shares.
11/21/17
ROTH
11/21/17
NO CHANGE
Target $127
ROTH
Buy
Shopify price target raised to $127 from $119 at Roth Capital
Roth Capital analyst Darren Aftahi raised his price target for Shopify (SHOP) to $127 to $119 following his recently hosted investor meetings with the company's management. The analyst believes opportunities for International, plus Facebook's (FB) Instagram and potentially new merchant solutions, should continue to drive both its P&L and shares higher, in what he views as early relative days in ramp of its platform. Aftahi reiterates a Buy rating on Shopify's shares.
GOOG Alphabet
$1,018.38

-0.71 (-0.07%)

11/15/17
BERN
11/15/17
NO CHANGE
Target $100
BERN
Outperform
Microsoft building for Cloud business larger than most expect, says Bernstein
Bernstein analyst Mark Moerdler notes that Microsoft (MSFT) has a much larger datacenter footprint compared to its peers such as AWS (AMZN) and Google (GOOG;GOOL). Looking at datacenter investment, the analyst thinks Microsoft is building for Cloud business larger than most expect, growth in Azure and Commercial Cloud should continue to remain strong, and given Microsoft Commercial cloud is already at AWS like GM, it should have even better GM as they fill into the built capacity. The analyst reiterates an Outperform rating and $100 price target on Microsoft's shares.
10/31/17
ROTH
10/31/17
NO CHANGE
Target $41
ROTH
Neutral
Yelp price target raised to $41 from $35 at Roth Capital
Roth Capital analyst Darren Aftahi raised his price target for Yelp (YELP) to $41 from $35 ahead of quarterly results. Nonethless, the analyst says that while Yelp has divested of Eat24, he sees its go-forward business as remaining challenged by the likes of Facebook (FB), Google (GOOG; GOOGL), and now to a lesser extent, Snap (SNAP). He reiterates a Neutral rating on Yelp's shares.
10/27/17
BARD
10/27/17
NO CHANGE
Target $1150
BARD
Outperform
Alphabet results show ability to adapt to changing trends, says Baird
Baird analyst Colin Sebastian said Alphabet reported impressive Q3 results which showed the company's ability to adapt quickly to changing internet, advertising, and commerce trends while leveraging its advanced AI/machine learning. Sebastian reiterated his Outperform rating and raised his price target to $1,150 from $1,100 on Alphabet shares.
GOOGL Alphabet Class A
$1,034.66

-1.23 (-0.12%)

10/27/17
RBCM
10/27/17
NO CHANGE
RBCM
Alphabet Class A price target raised to $1,125 from $1,050 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Alphabet Class A to $1,125 from $1,050 and maintained an Outperform rating, citing an impressive Q3 where all fundamental trends were positive, including year-over-year revenue growth and operating margin expansion.
AMZN Amazon.com
$1,126.31

-3.57 (-0.32%)

11/21/17
COWN
11/21/17
NO CHANGE
COWN
Amazon pharmacy opportunity not as big as expected, says Cowen
Cowen analyst John Blackledge analyzed the opportunity for Amazon (AMZN) in the pharmacy business and concluded it may not be as big as expected and is multiple times smaller than in the apparel, consumables, and grocery verticals. He believes, if launched, a pharmacy business could be done via Whole Foods and multiple Prime platforms, but there could be several friction points. The analyst also makes a case for an acquisition of Rite-Aid (RAD), which would allow Amazon to obtain state pharmacy licenses, add infrastructure, acquire a small PBM, gain access to retail network contracts for reimbursement, and add immediate scale. Also, if Amazon launched through Whole foods, the Rite-Aid acquisition would accelerate market share gains and other positive scenarios, said Blackledge in his note to investors.
11/21/17
WEDB
11/21/17
NO CHANGE
WEDB
Amazon flywheel turning faster in hardlines retail, says Wedbush
Wedbush analyst Seth Basham hosted an Advisor call with John Richards, Former VP of Customer Experience at Amazon.com, and came away thinking that the e-Commerce giant will be able to garner considerably more than 2% market share the company enjoys in auto parts and home improvement retail categories, and that elements are in place for more of these categories to grow much faster than the 30% Amazon total store growth rate in the medium-term. At a minimum, bricks and mortar retailers will need to maintain investment levels to compete with Amazon, he contends.
11/20/17
MSCO
11/20/17
INITIATION
MSCO
Overweight
National Vision initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Simeon Gutman started National Vision (EYE) with an Overweight rating and $36 price target, saying he believes the company's long runway for store expansion and predictable cash flow growth merit a premium valuation while its high service component give it a low Amazon (AMZN) risk.
11/20/17
11/20/17
NO CHANGE

Amazon disruption of healthcare 'a foregone conclusion,' says Morgan Stanley
Morgan Stanley's U.S. Internet and Healthcare teams collaborated on a report exploring Amazon's (AMZN) entry into healthcare, stating that it will likely take time but that the e-commerce giant's "disruption of healthcare is a foregone conclusion." While retail plays to Amazon's strengths with the highest profits and lowest barriers to entry, retailers like CVS (CVS) and Walgreens (WBA) have the most opportunities to adjust their business models and lower costs to defend against Amazon, the teams tell investors. Medical supply and Life Sciences distribution are "less rich" targets, but look like "low-hanging fruit," the analysts added. Cardinal Health (CAH) has the most exposure via its medical supply distribution segment, said the firm, which downgraded Cardinal to Underweight from Equal Weight, as previously reported. McKesson (MCK) also has some, but less, risk and AmerisourceBergen (ABC), which doesn't distribute medical supplies, remains immune in the near-term, the firm concluded. Others in healthcare distribution facing the most share and/or margin risk from Amazon include Thermo Fisher (TMO), Henry Schein (HSIC) and Patterson (PDCO), the firm added.
NFLX Netflix
$194.10

0.9 (0.47%)

10/17/17
BOFA
10/17/17
NO CHANGE
Target $225
BOFA
Buy
Netflix price target raised to $225 from $199 at BofA/Merrill
10/23/17
NEED
10/23/17
INITIATION
Target $28
NEED
Buy
Roku initiated with a Buy at Needham
Needham analyst Laura Martin initiated Roku (ROKU) with a Buy rating and a price target of $28. Martin says that comparable to Netflix (NFLX), Roku is a pure play on the growth of over-the-top video, but has no risks related to content. Martin adds that Roku is also a more attractive acquisition target, while its 3-times FY18 revenue valuation is well below 7-times one at Netflix despite the comparable FY18 revenue growth expectations.
10/26/17
LOOP
10/26/17
NO CHANGE
Target $237
LOOP
Buy
Netflix price target lowered to $237 from $242 at Loop Capital
Loop Capital analyst David Miller trimmed his price target for Netflix shares to $237 to reflect this week's announced $1.6B bond offering. The analyst notes the second season of "Stranger Things," one of the more popular original series on Netflix, will be available for streaming beginning tomorrow. He keeps a Buy rating on the shares.
10/17/17
MSCO
10/17/17
NO CHANGE
Target $235
MSCO
Overweight
Netflix price target raised to $235 after earnings at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne raised his price target on Netflix to $235 from $225 following the company's Q3 earnings report, saying that its guidance for Q4 subscriber additions suggests the company sees its broader secular momentum, its strong content slate and seasonal viewing offsetting any churn impact from price increases. He keeps an Overweight rating on Netflix shares, which are little changed in pre-market trading following last night's quarterly letter to investors and associated call.

TODAY'S FREE FLY STORIES

WEN

Wendy's

$15.63

0.24 (1.56%)

, MCD

McDonald's

$173.35

-0.2 (-0.12%)

15:41
12/14/17
12/14
15:41
12/14/17
15:41
Hot Stocks
Chanos says he'd short almost all fast food stocks, except McDonald's »

While being interviewed…

WEN

Wendy's

$15.63

0.24 (1.56%)

MCD

McDonald's

$173.35

-0.2 (-0.12%)

QSR

Restaurant Brands

$61.49

0.16 (0.26%)

YUM

Yum! Brands

$82.12

-0.07 (-0.09%)

JACK

Jack in the Box

$102.49

-0.09 (-0.09%)

SONC

Sonic

$28.32

0.38 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

SLM

Sallie Mae

$11.16

-0.45 (-3.88%)

15:40
12/14/17
12/14
15:40
12/14/17
15:40
Options
Sallie Mae sees notable call buying »

Sallie Mae sees notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$39.53

0.24 (0.61%)

, PRGO

Perrigo

$82.91

-3.11 (-3.62%)

15:36
12/14/17
12/14
15:36
12/14/17
15:36
Periodicals
Mylan, Perrigo among those interesed in Merck KGaA unit, Bloomberg says »

Mylan (MYL), Perrigo…

MYL

Mylan

$39.53

0.24 (0.61%)

PRGO

Perrigo

$82.91

-3.11 (-3.62%)

MKGAY

Merck KGaA

RBGLY

Reckitt Benckiser

$18.17

0.11 (0.61%)

NSRGY

Nestle

$86.67

0.61 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$26.16

0.62 (2.43%)

15:34
12/14/17
12/14
15:34
12/14/17
15:34
Periodicals
Airbus COO expected to step down, Reuters reports »

Airbus COO and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil Circuit

$27.56

-0.99 (-3.47%)

15:34
12/14/17
12/14
15:34
12/14/17
15:34
Options
Jabil Circuit options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 09

    Jan

MCD

McDonald's

$173.34

-0.21 (-0.12%)

, QSR

Restaurant Brands

$61.42

0.09 (0.15%)

15:32
12/14/17
12/14
15:32
12/14/17
15:32
Hot Stocks
Jim Chanos says not short McDonald's, but is short other fast food stocks »

Chanos, in making…

MCD

McDonald's

$173.34

-0.21 (-0.12%)

QSR

Restaurant Brands

$61.42

0.09 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$10.30

-0.66 (-6.02%)

15:30
12/14/17
12/14
15:30
12/14/17
15:30
Options
Express calls active as shares see relative weakness »

Express calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

, DIS

Disney

$111.17

3.555 (3.30%)

15:29
12/14/17
12/14
15:29
12/14/17
15:29
Recommendations
21st Century Fox, Disney analyst commentary  »

21st Century Fox should…

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

DIS

Disney

$111.17

3.555 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

TSLA

Tesla

$339.03

-2 (-0.59%)

15:28
12/14/17
12/14
15:28
12/14/17
15:28
Hot Stocks
Tesla 'already behind' on vehicle autonomy, Chanos says »

Jim Chanos of Kynikos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$339.03

-2 (-0.59%)

15:27
12/14/17
12/14
15:27
12/14/17
15:27
Hot Stocks
Chanos says Tesla CEO Musk 'has broad interpretation of truth' »

Jim Chanos, who is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

BTC

Bitcoin

, BITCOIN

Bitcoin

15:19
12/14/17
12/14
15:19
12/14/17
15:19
General news
Chanos says 'not short' bitcoin but 'speculation' in it indicative of market »

Jim Chanos of Kynikos…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$176.83

4.29 (2.49%)

15:19
12/14/17
12/14
15:19
12/14/17
15:19
Options
Adobe options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EADSY

Airbus

$26.16

0.62 (2.43%)

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Periodicals
Breaking Periodicals news story on Airbus »

Airbus CEO intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

, ESRX

Express Scripts

$68.57

0.01 (0.01%)

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Periodicals
Chanos says tax bill will affect healthcare more than people think »

Chanos mentioned…

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

ESRX

Express Scripts

$68.57

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

$NYE

NYSE Market Internals

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

15:12
12/14/17
12/14
15:12
12/14/17
15:12
Periodicals
Speaker Ryan says not leaving Congress anytime soon, CBS News reports »

Following a media report…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$2.93

-0.095 (-3.15%)

15:10
12/14/17
12/14
15:10
12/14/17
15:10
Options
Bulls and bears in JC Penney Thursday »

Bulls and bears in JC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

, CMCSK

Comcast

15:06
12/14/17
12/14
15:06
12/14/17
15:06
Periodicals
Comcast offered more for Fox assets, but Fox preffered Disney deal, CNBC says »

Sources tell CNBC's…

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

CMCSK

Comcast

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

COST

Costco

$188.28

-0.02 (-0.01%)

15:04
12/14/17
12/14
15:04
12/14/17
15:04
Options
Costco options imply 5.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VRX

Valeant

$19.22

-2.83 (-12.83%)

15:03
12/14/17
12/14
15:03
12/14/17
15:03
Technical Analysis
Technical View: Valeant near session lows, levels to watch »

The shares are bouncing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 27

    Dec

  • 18

    Jun

CI

Cigna

$204.17

-3.75 (-1.80%)

15:02
12/14/17
12/14
15:02
12/14/17
15:02
Hot Stocks
Cigna announces acquisition of digital health plan platform Brighter »

Cigna announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/14/17
12/14
15:00
12/14/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

ORCL

Oracle

$50.25

0.195 (0.39%)

14:49
12/14/17
12/14
14:49
12/14/17
14:49
Options
Oracle options imply 7.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DIS

Disney

$111.04

3.43 (3.19%)

, FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

14:44
12/14/17
12/14
14:44
12/14/17
14:44
Recommendations
Disney, 21st Century Fox analyst commentary  »

RBC Capital sees Disney,…

DIS

Disney

$111.04

3.43 (3.19%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.